Bromocriptine formulations

A dosage form comprising

• micronized bromocriptine mesylate and one or more excipients in the form of an oral tablet;
• wherein the micronized bromocriptine mesylate is present in an amount that provides a dose of at least about 0.8 mg of bromocriptine per said oral tablet;
• and
• wherein the micronized bromocriptine mesylate has a Dv90 of less than about 20 μm, a Dv50 of about 7.2 μm or less, a Dv10 of about 2.5 μm or less, and has a particle size distribution with a span of about 1.8 or lower, and not more than about 20% of the bromocriptine mesylate has a particle size of less than 1 μm;
• and
• wherein the oral tablet has a dissolution profile wherein not more than 50% of the bromocriptine mesylate has been released at about 7 minutes, not more than about 75% of the bromocriptine mesylate has been released at about 10 minutes, and wherein at least about 90% of the bromocriptine mesylate has been released at about 30 minutes, when tested in USP Apparatus Type 2 Paddle Method at 50 rpm in 500 mL of 0.1 N hydrochloric acid at about 37° C.